INNOVATE Corp.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
VATE$5.11-5.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(Unaudited, in millions)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities | ||
| Net loss | $(17.1) | $(25.8) |
| Adjustments to reconcile net loss to cash provided by (used in) operating activities | ||
| Share-based compensation expense | 0.6 | 0.8 |
| Depreciation and amortization (including amounts in cost of revenue) | 7.4 | 7.9 |
| Amortization of deferred financing costs and debt discount | 6.1 | 5.6 |
| Loss from equity investees | — | 5.9 |
| Gains on investments | — | (4.6) |
| Deferred income tax expense | — | 0.1 |
| Other operating activities, net | — | 0.3 |
| Changes in assets and liabilities: | ||
| Accounts receivable | 55.0 | 29.2 |
| Contract assets | 9.6 | (29.0) |
| Other current assets | 3.2 | 1.4 |
| Inventory | 0.6 | 1.1 |
| Other assets | 7.0 | 2.4 |
| Accounts payable | (14.2) | 19.3 |
| Accrued liabilities | 6.0 | (10.9) |
| Contract liabilities | (14.6) | (13.8) |
| Other current liabilities | 0.9 | — |
| Other liabilities | (5.0) | (4.0) |
| Cash provided by (used in) operating activities | 45.5 | (14.1) |
| Cash flows from investing activities | ||
| Purchase of property, plant and equipment | (9.5) | (4.7) |
| Proceeds from disposal of property, plant and equipment | 0.1 | 1.1 |
| Purchase of investments | — | (0.3) |
| Cash paid for asset acquisitions | (0.2) | — |
| Cash used in investing activities | (9.6) | (3.9) |
| Cash flows from financing activities | ||
| Proceeds from lines of credit, net of deferred financing costs | — | 20.0 |
| Payments on lines of credit | (10.0) | (15.0) |
| Principal payments for and repurchases of other debt obligations | (3.0) | (2.2) |
| Dividend payments | (0.4) | (0.3) |
| Other financing activities | (0.1) | (0.1) |
| Cash (used in) provided by financing activities | (13.5) | 2.4 |
| Effects of exchange rate changes on cash, cash equivalents and restricted cash | 0.1 | 0.2 |
| Net increase (decrease) in cash and cash equivalents, including restricted cash | 22.5 | (15.4) |
| Cash, cash equivalents and restricted cash, beginning of period | 112.7 | 49.3 |
| Cash, cash equivalents and restricted cash, end of period | $135.2 | $33.9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.